Trial Profile
Intravitreal bevacizumab injection for diabetic macular oedema and macular oedema due to central retinal vein occlusion.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Feb 2016
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 04 Feb 2016 New trial record